TABLE 2.
SURVIVAL CHARACTERISTICS OF PATIENTS WITH STAGES I-III DISEASE AT DIAGNOSIS
| Characteristic | N | Events | Median Overall Survival (months) |
Two-Year Overall Survival Rate (%) |
p-value |
|---|---|---|---|---|---|
| Overall Survival | 56 | 22 | 62.6 | 86.8 | |
| Age at Diagnosis | |||||
| Age < 50 years | 8 | 3 | 104.3 | 83.3 | 0.87 |
| Age ≥ 50 years | 48 | 21 | 54.5 | 85.4 | |
| Sex | |||||
| Male | 26 | 12 | 62.6 | 78.5 | 0.66 |
| Female | 30 | 12 | 54.5 | 95.7 | |
| T Stage | |||||
| T1 | -- | -- | -- | -- | 0.04 |
| T2 | 11 | 1 | 106.7 | 100.0 | |
| T3 | 35 | 17 | 54.1 | 86.7 | |
| T4 | 10 | 5 | 45.8 | 64.3 | |
| N Stage | |||||
| N0 | 23 | 6 | 104.3 | 100.0 | <0.01 |
| N1 | 15 | 6 | 54.5 | 83.3 | |
| N2 | 18 | 11 | 32.2 | 67.2 | |
| Site of Primary Tumor | |||||
| Right | 35 | 11 | 54.5 | 88.7 | 0.78 |
| Left | 12 | 8 | 45.8 | 64.1 | |
| Rectal | 9 | 5 | 62.6 | 100.0 | |
| BRAF Mutation Type | |||||
| V600E | 53 | 20 | 54.5 | 86.2 | 0.76 |
| D594G/N | 2 | 1 | 62.6 | 100.0 | |
| G496R | 1 | 1 | 45.8 | 100.0 |